Literature DB >> 7602092

MHC class I expression and transport in a calnexin-deficient cell line.

J E Scott1, J R Dawson.   

Abstract

The human leukemic cell line, CEM, and an NK-resistant variant of CEM, called CEM-NKR, were analyzed for protein differences by two-dimensional gel electrophoresis. One protein was found to be completely absent in CEM-NKR. This protein has been identified as calnexin. CEM-NKR also completely lacks calnexin RNA. Calnexin is thought to act as a molecular chaperone by assisting in the assembly and/or retention of MHC class I and many other membrane and secreted proteins. The surface expression of class I molecules on CEM-NKR was compared with CEM by several Abs. There was no significant class I expression differences between CEM and CEM-NKR using w6/32 (a conformational and beta 2-microglobulin-dependent mAb), HC-10 (a conformational and beta 2-microglobulin-independent mAb), and an anti-class I antiserum that reacts with native and denatured class I. The transport rate of class I in both cell lines was examined by pulse-chase experiments, immunoprecipitating class I with w6/32 and anti-class I antiserum. The results show that class I molecules in the calnexin-deficient cell line and its parent cell line are transported at similar rates. These results indicate that calnexin is not absolutely required for the viability of CEM or the transport and surface expression of human MHC class I molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.

Authors:  S Lee; J Yoon; B Park; Y Jun; M Jin; H C Sung; I H Kim; S Kang; E J Choi; B Y Ahn; K Ahn
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.

Authors:  Elias T Spiliotis; Tsvetelina Pentcheva; Michael Edidin
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

Review 3.  Assembly of MHC class I molecules within the endoplasmic reticulum.

Authors:  Yinan Zhang; David B Williams
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 5.  Thiol oxidation and reduction in MHC-restricted antigen processing and presentation.

Authors:  P Cresswell; B Arunachalam; N Bangia; T Dick; G Diedrich; E Hughes; M Maric
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules.

Authors:  Syed Monem Rizvi; Natasha Del Cid; Lonnie Lybarger; Malini Raghavan
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

Review 7.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression.

Authors:  Angela Denzel; Maurizio Molinari; Cesar Trigueros; Joanne E Martin; Shanti Velmurgan; Sue Brown; Gordon Stamp; Michael J Owen
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 9.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

10.  Association of beta2-microglobulin with the alpha3 domain of H-2Db heavy chain.

Authors:  Mirjana Lilić; Zoran Popmihajlov; John J Monaco; Stanislav Vukmanović
Journal:  Immunogenetics       Date:  2004-01-20       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.